Literature DB >> 10973217

Cytokine production in motor neurons by poliovirus replicon vector gene delivery.

A W Bledsoe1, C A Jackson, S McPherson, C D Morrow.   

Abstract

Poliovirus replicon vectors transiently express foreign proteins selectively in motor neurons of the anterior horn of the spinal cord. Here we intraspinally inoculated mice transgenic for the poliovirus receptor (PVR) with replicons encoding murine tumor necrosis factor alpha (mTNF-alpha). We detected high-level expression of mTNF-alpha in the spinal cords of these animals at 8-12 h post inoculation; this returned to background by 72 h. The mice exhibited ataxia and tail atony, whereas animals given a replicon encoding green fluorescent protein (GFP) exhibited no neurological symptoms. Histology of spinal cords from mice given the replicon encoding mTNF-alpha revealed neuronal chromatolysis, reactive astrogliosis, decreased expression of myelin basic protein, and demyelination. These animals recovered with only slight residual damage. This study shows that replicon vectors have potential for targeted delivery of therapeutic proteins to the central nervous system and provide a new approach for treatment of spinal cord trauma and neurological disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973217     DOI: 10.1038/79455

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  9 in total

Review 1.  Viral vectors for therapy of neurologic diseases.

Authors:  Sourav R Choudhury; Eloise Hudry; Casey A Maguire; Miguel Sena-Esteves; Xandra O Breakefield; Paola Grandi
Journal:  Neuropharmacology       Date:  2016-02-21       Impact factor: 5.250

2.  Glial activation and segmental upregulation of interleukin-1beta (IL-1beta) in the rat spinal cord after surgical incision.

Authors:  Di Fu; Qulian Guo; Yuhang Ai; Hongwei Cai; Jianqin Yan; Ruping Dai
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

3.  Polio, still lurking in the shadows.

Authors:  Anthony N van den Pol
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

4.  Expression of brain-derived neurotrophic factor in the central nervous system of mice using a poliovirus-based vector.

Authors:  Qingmei Jia; Fengyi Liang; Seii Ohka; Akio Nomoto; Tsutomu Hashikawa
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

5.  Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors.

Authors:  S Crotty; C J Miller; B L Lohman; M R Neagu; L Compton; D Lu; F X Lü; L Fritts; J D Lifson; R Andino
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system.

Authors:  Sang-Gu Lee; Dae-You Kim; Byung-Hwa Hyun; Yong-Soo Bae
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 7.  Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.

Authors:  David S Strayer; Lokesh Agrawal; Pierre Cordelier; Bianling Liu; Jean-Pierre Louboutin; Elena Marusich; Hayley J McKee; Carmen N NiGongyi Ren; Marlene S Strayer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.860

Review 8.  Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.

Authors:  Amish C Shah; Dale Benos; G Yancey Gillespie; James M Markert
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.506

9.  A Sabin 1 poliovirus-based vaccine vector transfects Vero cells with high efficiency.

Authors:  Changgui Li; Wei Han; Yingqi Zhang; Junzhi Wang
Journal:  Cytotechnology       Date:  2007-07-11       Impact factor: 2.058

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.